Global Markets Direct Market Research Reports

Title published price

Progressive Supranuclear Palsy - Pipeline Review, H1 2016

By Global Markets Direct

Global Markets Direct's, ‘Progressive Supranuclear Palsy - Pipeline Review, H1 2016', provides an overview of the Progressive Supranuclear Palsy pipeline landscape. The report provides comprehensive information on the therapeutics unde ...

22-Jun-2016 $2000

Burkholderia Infections - Pipeline Review, H1 2016

By Global Markets Direct

Global Markets Direct's, ‘Burkholderia Infections - Pipeline Review, H1 2016', provides an overview of the Burkholderia Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development ...

22-Jun-2016 $2000

Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H1 2016

By Global Markets Direct

Global Markets Direct's, ‘Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H1 2016', provides an overview of the Hyperphosphatemia In Chronic Kidney Disease pipeline landscape. The report provides comprehensive informatio ...

22-Jun-2016 $2000

Acute Lung Injury - Pipeline Review, H1 2016

By Global Markets Direct

Global Markets Direct's, ‘Acute Lung Injury - Pipeline Review, H1 2016', provides an overview of the Acute Lung Injury pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acute Lu ...

22-Jun-2016 $2000

Liver Cancer - Pipeline Review, H1 2016

By Global Markets Direct

Global Markets Direct's, ‘Liver Cancer - Pipeline Review, H1 2016', provides an overview of the Liver Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Liver Cancer, comp ...

22-Jun-2016 $2500

Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016

By Global Markets Direct

Global Markets Direct's, ‘Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016', provides an overview of the Glioblastoma Multiforme (GBM) pipeline landscape. The report provides comprehensive information on the therapeutics under ...

22-Jun-2016 $2500

XOMA Corporation - Product Pipeline Review - 2016

By Global Markets Direct

Global Markets Direct's, ‘XOMA Corporation - Product Pipeline Review - 2016', provides an overview of the XOMA Corporation's pharmaceutical research and development focus. The report provides comprehensive information on the therapeuti ...

22-Jun-2016 $1500

Pfenex Inc. - Product Pipeline Review - 2016

By Global Markets Direct

Global Markets Direct's, ‘Pfenex Inc. - Product Pipeline Review - 2016', provides an overview of the Pfenex Inc.'s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under d ...

22-Jun-2016 $1500

La Jolla Pharmaceutical Company - Product Pipeline Review - 2016

By Global Markets Direct

Global Markets Direct's, ‘La Jolla Pharmaceutical Company - Product Pipeline Review - 2016', provides an overview of the La Jolla Pharmaceutical Company's pharmaceutical research and development focus. The report provides comprehensive ...

22-Jun-2016 $1500

BioMarin Pharmaceutical Inc. - Product Pipeline Review - 2016

By Global Markets Direct

Global Markets Direct's, ‘BioMarin Pharmaceutical Inc. - Product Pipeline Review - 2016', provides an overview of the BioMarin Pharmaceutical Inc.'s pharmaceutical research and development focus. The report provides comprehensive infor ...

22-Jun-2016 $1500

Advinus Therapeutics Ltd - Product Pipeline Review - 2016

By Global Markets Direct

Global Markets Direct's, ‘Advinus Therapeutics Ltd - Product Pipeline Review - 2016', provides an overview of the Advinus Therapeutics Ltd's pharmaceutical research and development focus. The report provides comprehensive information o ...

22-Jun-2016 $1500

Programmed Cell Death 1 Ligand 1 (PD-L1 or B7 Homolog 1 or B7-H1 or CD274) - Pipeline Review, H1 2016

By Global Markets Direct

Global Markets Direct's, ‘Programmed Cell Death 1 Ligand 1 (PD-L1 or B7 Homolog 1 or B7-H1 or CD274) - Pipeline Review, H1 2016', provides in depth analysis on Programmed Cell Death 1 Ligand 1 (PD-L1 or B7 Homolog 1 or B7-H1 or CD274) targeted pipeli ...

22-Jun-2016 $3500

Proprotein Convertase Subtilisin/Kexin Type 9 (Proprotein Convertase 9 or Neural Apoptosis-Regulated Convertase 1 or PCSK9 or EC 3.4.21.) - Pipeline Review, H1 2016

By Global Markets Direct

Global Markets Direct's, ‘Proprotein Convertase Subtilisin/Kexin Type 9 (Proprotein Convertase 9 or Neural Apoptosis-Regulated Convertase 1 or PCSK9 or EC 3.4.21.) - Pipeline Review, H1 2016', provides in depth analysis on Proprotein Convertase Subti ...

22-Jun-2016 $3500

Coagulation Factor XI (Plasma Thromboplastin Antecedent or EC 3.4.21.27) - Pipeline Review, H1 2016

By Global Markets Direct

Global Markets Direct's, ‘Coagulation Factor XI (Plasma Thromboplastin Antecedent or EC 3.4.21.27) - Pipeline Review, H1 2016', provides in depth analysis on Coagulation Factor XI (Plasma Thromboplastin Antecedent or EC 3.4.21.27) targeted pipeline t ...

22-Jun-2016 $3500

Receptor Tyrosine Protein Kinase ERBB 4 (Tyrosine Kinase Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1) - Pipeline Review, H1 2016

By Global Markets Direct

Global Markets Direct's, ‘Receptor Tyrosine Protein Kinase ERBB 4 (Tyrosine Kinase Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1) - Pipeline Review, H1 2016', provides in depth an ...

22-Jun-2016 $3500

Glycogen Synthase Kinase 3 Beta (GSK-3 Beta or EC 2.7.11.26) - Pipeline Review, H1 2016

By Global Markets Direct

Global Markets Direct's, ‘Glycogen Synthase Kinase 3 Beta (GSK-3 Beta or EC 2.7.11.26) - Pipeline Review, H1 2016', provides in depth analysis on Glycogen Synthase Kinase 3 Beta (GSK-3 Beta or EC 2.7.11.26) targeted pipeline therapeutics. ...

22-Jun-2016 $3500

Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H1 2016

By Global Markets Direct

Global Markets Direct's, ‘Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H1 2016', provides in depth analysis on Granulocyte Macrophage Colony St ...

22-Jun-2016 $3500

P-Selectin (Granule Membrane Protein 140 or Platelet Activation Dependent Granule-External Membrane Protein or CD62P) - Pipeline Review, H1 2016

By Global Markets Direct

Global Markets Direct's, ‘P-Selectin (Granule Membrane Protein 140 or Platelet Activation Dependent Granule-External Membrane Protein or CD62P) - Pipeline Review, H1 2016', provides in depth analysis on P-Selectin (Granule Membrane Protein 140 or Pla ...

22-Jun-2016 $3500

20s Proteasome - Pipeline Review, H1 2016

By Global Markets Direct

Global Markets Direct's, ‘20s Proteasome - Pipeline Review, H1 2016', provides in depth analysis on 20s Proteasome targeted pipeline therapeutics. The report provides comprehensive information on the 20s Proteasome , targeted therapeut ...

22-Jun-2016 $3500

Gamma Secretase (EC 3.4.23.46) - Pipeline Review, H1 2016

By Global Markets Direct

Global Markets Direct's, ‘Gamma Secretase (EC 3.4.23.46) - Pipeline Review, H1 2016', provides in depth analysis on Gamma Secretase (EC 3.4.23.46) targeted pipeline therapeutics. The report provides comprehensive information on the Gam ...

22-Jun-2016 $3500